HIV Archives

Lenacapavir Manufacturing In SA: Strengthening Production

Lenacapavir manufacturing in SA aims to strengthen supply chains and provide critical HIV prevention solutions.

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here

Roche Integration Accelerated: A New Era for Testing

Learn how Roche Integration Accelerated enhances access to essential testing for TB, HIV, HPV, and Hepatitis in Africa.

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here

HPV Vaccination: School Vaccination Programme Cuts Risk

Find out how South Africa’s HPV vaccination drive protects teenagers and reduces the incidence of high-risk HPV strains linked to cancer.

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here

HIV Prevention Shot Lenacapavir: Aspen Warns of Demand Risks

Learn about the HIV prevention shot lenacapavir and why Aspen Pharmacare emphasises guaranteed demand for local production.

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here

AIDS Drug Tender Controversy Raises Serious Questions

Delve into the AIDS Drug Tender Controversy where Motsoaledi points to the DG in the R15.5bn ARV procurement scandal.

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here

Lenacapavir HIV Prevention Injection to Reach Too Few

South Africa’s first consignment of lenacapavir, a six-monthly HIV prevention injection for high-risk HIV-negative people, will cover fewer than a quarter of the target population. Deliveries are underway and will continue through April. Rollout will begin immediately after delivery, with an initial two-year implementation plan…. Membership Required You must be a member to access this...

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here

Barrs Pharmaceuticals Secures R92m Hetero Investment

Barrs Pharmaceuticals has exited business rescue after agreeing to sell a controlling stake to Hetero. The deal signals a reset for a local manufacturer that has faced both operational disruption and regulatory pressure…. Membership Required You must be a member to access this content.View Membership LevelsAlready a member? Log in here...